Form 4: Genelux Corp Director Mirabelli Reports Transaction
SEC Form 4 Filing
Director Mary Mirabelli reports the acquisition and disposal of common stock and warrants of Genelux Corp on May 29, 2024.
Summary
- On May 29, 2024, Mary Mirabelli, a director of Genelux Corp, reported a transaction involving the company's securities.
- The transaction included the acquisition of 8,000 shares of common stock.
- The transaction also included the disposal of 12,460 shares of common stock.
- Additionally, Mirabelli acquired 8,000 warrants to purchase common stock at an exercise price of $5.25, exercisable immediately and expiring on May 29, 2029.
- The shares of common stock were sold together with accompanying warrants to purchase common stock at a combined price of $4.00 per share and warrant.
Sentiment
Score: 5
Explanation: This is a neutral report of a director's trading activity. The sentiment is neither positive nor negative as it simply reflects required disclosures.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's securities. It allows investors to monitor the actions of those with privileged information.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company directors as an indicator of confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction involving common stock and warrants. |
| 05/29/2029 | Expiration date of the acquired warrants. |
| 06/07/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.